Navigation Links
GeoVax Labs, Inc. Announces Resignation of Director
Date:7/6/2009

ATLANTA, July 6 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based HIV/AIDS vaccine development company, announced today that Mr. Andrew Kandalepas has resigned from his positions as Senior Vice President and Director of the Company.

Don Hildebrand, Chairman of the Board of Directors of GeoVax Labs, Inc., noted, "We all appreciate his dedication and service to the Company and thank Andy for his positive energy and enthusiasm." He also stated, "Andy has committed to remain supportive of the Company and we will be pursuing a consulting arrangement with Andy to assist us in many important activities of the Company."

Mr. Kandalepas was Chairman of the Board, President and Chief Executive Officer of Dauphin Technology from 1995 until the merger with GeoVax, Inc., in September 2006, at which time he assumed the position of Senior Vice President and remained a director of the Company. Mr. Kandalepas has a varied 30-plus year career as an entrepreneur and executive manager. Mr. Kandalepas earned his Electronics Engineering Degree from DeVry Institute of Technology.

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become infected. GeoVax AIDS vaccines also may be effective as therapeutics (treatment of people already infected with AIDS virus).

GeoVax's core AIDS vaccine technologies were developed by Dr. Harriet Robinson, Senior V.P. of Research and Development, through a
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois
2. GeoVax to Exhibit at the 2009 BIO International Convention
3. GeoVax Labs, Inc. Announces First Quarter Financial Results
4. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
5. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
6. GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
7. GeoVax to Present at the BIO CEO & Investor Conference 2009
8. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
9. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
10. GeoVax Presents Data at AIDS Vaccine 2008 Conference
11. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... EpiVax, Inc. today announced a collaborative r... RHHBY) aimed at evaluating EpiVax’s proprie... reduce detrimental immune responses to certain dr...on, the EpiVax Tregitope technology will be evalua...ein therapeutics. , (Vocu...
(Date:12/1/2009)...LIS and NORTH VANCOUVER, British Columbia, Dec. 1 ...wholly owned subsidiary of The Dow Chemical Compan...oday announced the signing of a research and comme...ides Dow AgroSciences with access to Agrisoma,s pr...n an exclusive basis in major food crops, and on a...
(Date:12/1/2009)... DNA Genotek, a leading provider of products fo...at Tepnel Pharmaceutical Services will offer Orage...nucleic acid extraction and genotyping service. ,...er 1, 2009 -- DNA Genotek , a leading provider of...announced that Tepnel Pharmaceutical Services wi...
(Date:12/1/2009)... Michael R. Drapp, a 34-year veteran of the hig...Technologies, a business development and intellect...rging nanotechnology space. The company also plan... nanotechnology incubator. , ...ael R. Drapp , a 34-year veteran of the high-techn...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4
...AND RAPIDS, Mich., Nov. 12 /PRNewswire/ - The Cent... is one of the first Midwest-based,laboratories to...ians with,patients suffering from metastatic breas...e FDA-approved CellSearch System is the first diag...rculating tumor cells (CTCs) in the,bloodstream fr...
...ronto Stock Exchange Symbol: MS, EDMONTON, Nov. 1...X:,MS), a leading developer in the treatment of mu...han 133 patients have been enrolled in its MAESTRO...98 for the treatment of,secondary progressive mult...acy analysis will be performed on data from the fi...
...STERDAM, Netherlands, Nov. 12 Eurand N.V.,(Nasdaq... develops enhanced,pharmaceutical and biopharmaceu...lation technologies, announced today that the Comp...Biotechnology Index (Nasdaq: NBI ),effective Nove...fficer of Eurand, commented, "We are,delighted to ...
Other Biology Technology:Center for Molecular Medicine One of the First Midwest Labs to Offer Advanced Test for Patients with Metastatic Breast Cancer 2BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial 2BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial 3Eurand Added to NASDAQ Biotechnology Index 2Eurand Added to NASDAQ Biotechnology Index 3
(Date:12/1/2009)...ad cold, can spread among groups of people, resear... California-San Diego and Harvard shows., Using ...s been following health conditions for more than 6...le tend to share their loneliness with others. Gra...people moves to the fringes of social networks., ...
(Date:11/30/2009)... from The Forsyth Institute, the University of Con...Center, have used state-of-the-art technology to e...allidum, the bacterium which causes syphilis. The ...ria can now be shown in three dimensions. This pro...eals previously unknown features, which may help f...
(Date:11/30/2009)...Journal of Experimental Biology are pleased to an...de la Recherche Scientifique (CNRS) in the Univers...year,s JEB Outstanding Paper Prize. ,The prize i...ment and is intended to encourage young scientists... and adds that ,we truly appreciate when authors s...
Breaking Biology News(10 mins):Loneliness can be contagious 2Loneliness can be contagious 3Scientists gain new understanding of disease-causing bacteria 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Mandatory alcohol testing for truck and bus drivers reduces alcohol involvement in fatal crashes 56938 1Mandatory alcohol testing for truck and bus drivers reduces alcohol involvement in fatal crashes 56938 2IAEA removes dangerous radioactive sources from Lebanon 9890 1IAEA removes dangerous radioactive sources from Lebanon 9890 2Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 1Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 2Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 3
...mson Family Cancer Research Institute of the Unive...ene important in embryo development leads to prema...lt mice. This gene, ATR, is essential for the body...ins in the DNA damage response underlie certain ty...work appears in the inaugural issue of Cell Stem C...
.... – Cold Spring Harbor Laboratory (CSHL) researche...ward Hughes Medical Investigator (HHMI) Greg Hanno...that enable a critical tumor suppressor network, c...t CSHL, we are moving simultaneously on several fr...to this pathway is something that almost all cance...
...bines, evolution of the length of nectar spurs--th... a way that allows flowers to match the tongue len...iologists have found. , The researchers were Juste...s and Scott Hodges of the University of California...l Science Foundation (NSF). Their results appear i...
Other Biology News:Loss of stem cells correlates with premature aging in animal study 2Study shows big power of small RNAs, not just proteins, in halting cancer 2Columbine flowers develop long nectar spurs in response to pollinators 2
Thermal Printer Paper, 10 rolls from Bio-Rad
Thermal Printer, for VersaFluor fluorometer, 120 V from Bio-Rad
...beled Substrates (red fluorescence; Ex=590 nm, Em=...activation • No lysing, fixing, or permeabili...ermeable, fluorescently labeled inhibitors of seri... activity in whole living cells. Select from sever...
...nown as ChemiArrayTM Mouse Cytokine Antibody Array...ethodologies. Besides the ability to detect protei...urate reflection of active cytokine levels because...fication step is needed. Furthermore, it is simple...
Biology Products: